Commodore Capital as of Sept. 30, 2021
Portfolio Holdings for Commodore Capital
Commodore Capital holds 29 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iveric Bio | 11.8 | $45M | 2.8M | 16.24 | |
| Aclaris Therapeutics (ACRS) | 10.4 | $39M | 2.2M | 18.00 | |
| Cytokinetics Com New (CYTK) | 7.5 | $29M | 797k | 35.74 | |
| Dicerna Pharmaceuticals | 6.9 | $26M | 1.3M | 20.16 | |
| C4 Therapeutics Com Stk (CCCC) | 5.7 | $22M | 481k | 44.68 | |
| Kura Oncology (KURA) | 4.9 | $19M | 999k | 18.73 | |
| Celcuity (CELC) | 4.4 | $17M | 921k | 18.00 | |
| Cogent Biosciences (COGT) | 4.2 | $16M | 1.9M | 8.41 | |
| Merus N V (MRUS) | 4.2 | $16M | 718k | 22.00 | |
| Cymabay Therapeutics | 4.0 | $15M | 4.2M | 3.65 | |
| Satsuma Pharmaceuticals Ord | 3.8 | $15M | 3.1M | 4.66 | |
| Vistagen Therapeutics Com New | 3.7 | $14M | 5.1M | 2.74 | |
| Celldex Therapeutics Com New (CLDX) | 3.5 | $13M | 248k | 53.99 | |
| Miragen Therapeutics (VRDN) | 2.9 | $11M | 668k | 16.45 | |
| Tenaya Therapeutics (TNYA) | 2.8 | $11M | 514k | 20.65 | |
| Iovance Biotherapeutics (IOVA) | 2.4 | $8.9M | 363k | 24.66 | |
| Xenon Pharmaceuticals (XENE) | 2.3 | $8.9M | 579k | 15.28 | |
| Protagonist Therapeutics (PTGX) | 2.3 | $8.8M | 498k | 17.72 | |
| Kronos Bio | 1.7 | $6.3M | 299k | 20.96 | |
| Revolution Medicines (RVMD) | 1.6 | $6.2M | 226k | 27.51 | |
| Genocea Biosciences Com New (GNCAQ) | 1.6 | $5.9M | 3.1M | 1.92 | |
| Kalvista Pharmaceuticals (KALV) | 1.4 | $5.5M | 313k | 17.45 | |
| Dyne Therapeutics (DYN) | 1.3 | $5.0M | 305k | 16.24 | |
| Mereo Biopharma Group Ads (MREO) | 1.3 | $4.8M | 2.0M | 2.42 | |
| Pmv Pharmaceuticals (PMVP) | 1.0 | $3.7M | 125k | 29.80 | |
| Inventiva Sa Ads (IVA) | 1.0 | $3.7M | 263k | 14.16 | |
| Bcls Acquisition Corp Com Cl A | 0.7 | $2.5M | 250k | 9.96 | |
| Astria Therapeutics (ATXS) | 0.6 | $2.1M | 239k | 8.84 | |
| Silverback Therapeutics (SPRY) | 0.3 | $969k | 97k | 9.97 |
